EPCS Compliance for EHR Vendors: Identity Proofing, Authentication, and DEA Alignment
Electronic prescribing of controlled substances (EPCS) is now a baseline expectation for an electronic health record (EHR) or electronic medical record (EMR) platform that supports prescribers. The federal SUPPORT Act requires electronic prescribing for Medicare Part D controlled substances, and most U.S. states have layered their own mandates on top, with more coming.
In the current regulatory environment, a customer evaluating EHR solutions will almost always ask how it handles EPCS before they sign. EHR vendors could build compliant EPCS software from scratch, but doing so is slow, expensive, and error-prone. A purpose-built service like Exostar’s ProviderPass streamlines EPCS compliance for EHRs with a single integration
What Is EPCS?
EPCS is the secure electronic transmission of Schedule II through Schedule V prescriptions from a prescriber to a pharmacy. The intent is to create a fast, secure electronic system that preserves the chain of custody that paper prescriptions provided with signatures and prescription pads.
The framework is defined by the Drug Enforcement Administration (DEA) under 21 CFR Part 1311, with technical requirements aligned to the NIST SP 800-63 family of digital identity standards.
DEA EPCS Requirements and NIST 800-63
DEA regulations rest on three compliance pillars, each mapped to a specific NIST 800-63-3 requirement:
- Identity proofing. Prescribers must be identity-proofed to IAL2 before they can issue controlled substance prescriptions.
- Two-factor authentication. Two-factor authentication is required under 21 CFR 1311.115 at the point of signing each prescription.
- Digital signature. Every prescription receives a cryptographic signature proving the verified prescriber issued it and that it has not been altered in transit.
The EHR application itself must also pass a third-party audit or certification before it can be used in production
EPCS Identity Proofing at IAL2
IAL2 identity proofing verifies that a prescriber is who they claim to be, using either remote or in-person evidence. A typical remote proofing flow includes:
- Live image capture. The prescriber’s face is captured live, with liveness detection to defeat spoofing.
- Government-issued ID capture. A driver’s license, passport, or equivalent is photographed and validated.
- Biometric or physical comparison. The live image is matched against the photo on the ID.
- Address confirmation. An enrollment code is delivered to a validated postal address.
- Optional supervised session. Prescribers who prefer a guided flow can complete identity proofing in a live webcam session with a trained agent.
Running this process takes substantial work, and most EHR vendors lean on a Credential Service Provider instead of building proofing infrastructure in-house. The right partner keeps the EHR vendor in direct control of the provider relationship, without inserting a separate identity layer between vendor and prescriber.
Two-Factor Authentication for EPCS
DEA two-factor authentication has a specific set of requirements. The second factor must be presented when the prescriber signs each controlled substance prescription, not once per session. Acceptable factors include a hardware OTP token, a mobile authenticator app on a device separate from the prescribing workstation, and biometrics that meet the requirements in 21 CFR 1311.116.
The range of acceptable tokens is useful because clinic environments vary enormously. Hardware tokens suit a pain clinic with stationary workstations, while mobile authentication may work better for a behavioral health practice whose prescribers are on the move.
ProviderPass offers prescribers a choice between hardware tokens and a mobile authenticator app, so EHR vendors do not have to deploy parallel authentication systems to satisfy their users.
Digital Signatures and PKI for EPCS
The signing requirement is satisfied through Public Key Infrastructure. Each prescription follows this flow:
- Hash the prescription. The application generates a cryptographic hash of the prescription contents when the prescriber authorizes it.
- Sign with the private key. The hash is signed using the prescriber’s private key, held inside a FIPS 140-2 Security Level 1 validated cryptographic module.
- Transmit to pharmacy. The signed prescription travels to the pharmacy over an encrypted channel.
- Verify at the pharmacy. The pharmacy verifies the signature against the matching public certificate before dispensing.
Any change to the prescription after signing breaks the signature and is detectable at the pharmacy.
EPCS Certification and Audit Readiness
Before an EPCS application can go live, it has to be audited or certified against 21 CFR Part 1311, and recertified every two years or whenever there is a change in EPCS functionality.
Periodic certification is only half of the picture. Providers also need to maintain an audit trail to prove day-to-day compliance. Identity proofing events and prescription signatures need to be logged and stored in a way that holds up to inspection.
ProviderPass maintains a tamper-evident audit trail by default, so EHR vendors inherit audit readiness rather than building log infrastructure of their own.
Simplifying EPCS Integration for Your EHR Platform
Building EPCS from scratch means standing up identity proofing, certificate issuance, token distribution, signing infrastructure, audit logging, and a recurring certification cycle. Exostar’s ProviderPass handles each of these, so EHR vendors can offer DEA-compliant electronic prescribing without the overhead of developing a solution from scratch.
ProviderPass simplifies EPCS in four ways:
- A single, developer-friendly API. All EPCS functions, including identity proofing, authentication, and digital signing, are exposed through one well-documented interface. Most partners go live in under four weeks, with project management and technical support included.
- Vendor control of identity. The EHR vendor retains ownership of the provider directory and the end-user experience. ProviderPass operates behind the scenes rather than inserting itself between vendor and prescriber.
- Multiple authentication methods. Prescribers can choose between hardware tokens and mobile authentication apps, both meeting DEA AAL2-equivalent requirements. Institutional proofing is also available for prescribers already verified by their organization.
- Audit logging done for you. Building compliance-grade logging is a project of its own, with strict requirements for inspection readiness. ProviderPass handles it as part of the integration.
ProviderPass currently supports 125,000+ prescribers and processes over half a billion controlled substance prescriptions annually across major EHR platforms.
EPCS Compliance FAQ
No, but many do. State requirements vary in scope, schedule coverage, exceptions, and penalties. The state rule controls where it is stricter than the federal SUPPORT Act.
Yes. Remote IAL2 proofing is an accepted path under DEA rules.
Not separate, but specialized. Most EHRs meet the requirement by integrating an EPCS service into the existing e-prescribing workflow instead of operating two systems in parallel.
Under six weeks is typical with a mature API and a focused implementation. Custom workflows or institutional proofing arrangements can extend that.
Streamline EPCS Compliance for Your EHR Platform
Exostar’s team can walk EHR and EMR developers through API integration, identity proofing options, and DEA compliance scope for their clinical environment. Talk to an EPCS integration specialist today.
